Publicacions
-
Chong AS, Roca C, Morales-Sánchez P, Dorca E, Barea V, Ruz-Caracuel I, Valderrabano P, Rovira-Zurriaga C, Jou-Munoz C, Bouron-Dal Soglio D, Chernock RD, Torrezan GT, Pusztaszeri M, Cameselle-Teijeiro JM, Matias-Guiu X, Alvarez CV, Salvador-Hernandez H, Wasserman JD, Leandro-García LJ, Foulkes WD, Andrés-León E, Casano-Sancho P and Rivera B.
Tracing the molecular route to progression in miRNA-biogenesis-defective thyroid lesions.
JCI Insight . 11(3): .
-
Cañada CF, Parcerisas JG, Prat-Bartomeu J, Salvador-Hernandez H, Cardeñosa AL, Puigventós E and Goldstein A.
Utilizing optical coherence tomography and machine learning to identify vision abnormalities in pediatric neurofibromatosis type 1 patients.
Scientific Reports . 16(1): .
-
CastilloSD, Perosanz X, Ressler AK, Ivars M, Rodriguez J, Rovira-Zurriaga C, Nola EM, Llena J, Grego-Bessa J, Roldan-Molina M, Arnau R, Martínez-Romero A, Barber-Martínez de la Torre I, Miguel Bejarano Serrano, Vicente-Villa MA, Celis-Passini V, Salvador-Hernandez H, Mora J, Marchuk DA, Baselga E and Graupera M.
Somatic Uniparental Disomy of PTEN in Endothelial Cells Causes Vascular Malformations in Patients with PTEN Hamartoma Tumor Syndrome
Cancer Discovery . 15(7): 1350-1362. Nº de cites: 8
-
Casano-Sancho P, Molina-Giraldo PX, Valls-Lafon A and Salvador-Hernandez H.
Growth hormone excess in children with neurofibromatosis and optic pathway glioma, an underdiagnosed condition: experience with long-acting treatment
EUROPEAN JOURNAL OF ENDOCRINOLOGY . 193(1): 129-134.
-
Marina Caballero Bellón, Santa-María López V, Marti-Sanchez L, Martorell-Sampol L, Salinas D, Hinojosa J, Becerra MV, Pavon-Mengual M, Morales-La Madrid A, Cruz-Martínez O, Muchart-Lopez J and Salvador-Hernandez H.
Very early-onset symptomatic CNS haemangioblastoma in Von Hippel-Lindau disease
JOURNAL OF MEDICAL GENETICS . 62(6): 409-412.
-
Salvador, L, del Valle, J, Dorca, E, Chong, AS, Chong, AL, Valenzuela, JC, Munté, E, Rioja, C, Marti-Sanchez L, Salinas, M, Darder, E, Fabian, MR, Brunet, J, Salvador-Hernandez H, Lázaro, C and Rivera, B.
DICER1 in pediatric and adult cancer predisposition populations: Prevalence, phenotypes, and mosaicism
GENETICS IN MEDICINE . 27(5): 101385-101385. Nº de cites: 2
-
Ortega-Bertran S, Fernández-Rodríguez J, Magallón-Lorenz M, Zhang X, Creus-Bachiller E, Diazgranados AP, Uriarte-Arrazola I, Mazuelas H, Blanco I, Valverde C, Carrió M, Villanueva A, De Raedt T, Romagosa C, Gel B, Salvador-Hernandez H, Ferrer M, Lázaro C and Serra E.
Triple Combination of MEK, BET, and CDK Inhibitors Significantly Reduces Human Malignant Peripheral Nerve Sheath Tumors in Mouse Models
CLINICAL CANCER RESEARCH . 31(5): 907-920. Nº de cites: 4
-
Camiña-Conforto G, Ivars M, Sarquella-Brugada G, Carlos Valera Dávila, Salvador-Hernandez H, Rovira-Zurriaga C and Baselga E.
Phacomatosis pigmentokeratotica: Exploring extracutaneous comorbidities and topical therapy
PEDIATRIC DERMATOLOGY . 41(5): 904-907.
-
Azizi, AA, Hargrave, D, Passos, J, Wolkenstein, P, Rosenbaum, T, Santoro, C, Rosenmayr, V, Pletschko, T, Ascierto, PA and Salvador-Hernandez H.
Consensus recommendations on management of selumetinib-associated adverse events in pediatric patients with neurofibromatosis type 1 and plexiform neurofibromas
Neuro-Oncology Practice . 11(5): 515-531. Nº de cites: 10
-
Viskochil, D, Wysocki, M, Learoyd, M, Sun, P, So, KR, Evans, A, Lai, FC and Salvador-Hernandez H.
Effect of food on selumetinib pharmacokinetics and gastrointestinal tolerability in adolescents with neurofibromatosis type 1-related plexiform neurofibromas
Neuro-Oncology Advances . 6(1): . Nº de cites: 4
